| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.94B | +5.2% |
| Cost of Revenue | $4.46B | +6.0% |
| R&D Expense | $236.6M | +7.2% |
| SG&A Expense | $696.9M | +2.9% |
| Operating Income | $1.78B | +4.2% |
| Pre-tax Income | $1.66B | +3.4% |
| Income Tax | $285.4M | -2.7% |
| Net Income | $1.38B | +4.8% |
| EPS (Basic) | $5.95 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $374.0M | -8.7% |
| Accounts Receivable | $948.8M | -6.3% |
| Inventory | $1.02B | -9.8% |
| Current Assets | $2.60B | -7.8% |
| Total Assets | $14.63B | -2.6% |
| Current Liabilities | $2.10B | -27.2% |
| Long-term Debt | $2.08B | -37.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.83B | +5.4% |
| Capital Expenditures | $127.1M | -6.7% |
| Investing Cash Flow | -$244.8M | +89.7% |
| Financing Cash Flow | -$1.60B | -329.8% |
| Free Cash Flow | $1.70B | +6.4% |
| +4.4% |
| EPS (Diluted) | $5.93 | +4.6% |
| Total Liabilities |
| $4.98B |
| -20.9% |
| Stockholders' Equity | $9.66B | +10.6% |